On May 8, 2025, analyst Bruce Jackson from Benchmark maintained a "Speculative Buy" rating for Genelux (GNLX, Financial) while adjusting the price target. The revised price target stands at $23.00 USD, marking a decrease from the previous target of $25.00 USD.
The adjustment signifies an 8.00% reduction in the stock's price target. Despite this decrease, the rating remains unchanged, reflecting continued investor interest and potential in Genelux (GNLX, Financial).
This update on Genelux (GNLX, Financial) is based on the latest analysis from Benchmark, offering insights for investors tracking the stock's performance.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 5 analysts, the average target price for Genelux Corp (GNLX, Financial) is $17.60 with a high estimate of $31.00 and a low estimate of $8.00. The average target implies an upside of 606.83% from the current price of $2.49. More detailed estimate data can be found on the Genelux Corp (GNLX) Forecast page.
Based on the consensus recommendation from 5 brokerage firms, Genelux Corp's (GNLX, Financial) average brokerage recommendation is currently 1.8, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
